Table 3 Prevalence of metabolic abnormalities in patients with schizophrenia n (%)
From: Prevalence of metabolic syndrome among patients with schizophrenia in Ethiopia
NECP ATP III | Total | Male | Female | OR female to male (95% CI) | P value | Â |
|---|---|---|---|---|---|---|
WC (M > 102 cm; F > 88 cm) | 50(25.0) | 9(7.0) | 41(57.7) | 18.2(8.0–41.6) | < 0.001 |  |
Triglycerides (≥ 150 mg/dl) | 61(30.7) | 44(34.4) | 17(23.9) | 0.6(0.3–1.2) | 0.126 |  |
BP (≥ 130/85 mmHg) | 74(37.0) | 50(38.8) | 24(33.8) | 0.8(0.4–1.5) | 0.487 |  |
HDL Cholesterol (M < 40 mg/dl; F < 50 mg/dl) | 88(44.4) | 54(42.5) | 34(47.9) | 1.24(0.7–2.2) | 0.466 |  |
FPG (≥100 mg/dl) | 49(24.9) | 27(21.3) | 22(31.4) | 1.7(0.8–3.3) | 0.114 |  |